General Meeting

General Meeting

The general meeting is Ascelia Pharma’s highest decision-making body. At the general meeting, the shareholders exercise their voting rights in key issues. To attend and vote at the general meeting, either in person or through a proxy, shareholders must be registered in the share register kept by Euroclear Sweden AB five business days prior to the meeting and also register their participation to Ascelia Pharma no later than on the date specified in the notice convening the meeting.

EGM 2021

An extraordinary general meeting will be held on Tuesday 13 April 2021 following board of directors’ resolution on directed issue of shares. No physical meeting and voting in advance due to Covid-19.

Annual General Meeting 2021

The AGM of Ascelia Pharma AB (publ) will be held on 5 May. No physical meeting and voting in advance due to Covid-19.

Shareholders wishing to have a matter discussed at the AGM should send their suggestion by e-mail to: or by mail to:

Hyllie Boulevard 34
SE-215 32 Malmö

Suggestions to the AGM must reach the Board of Directors at least seven weeks prior to the meeting or in good time for the matter, if necessary, can be included in the notice to the AGM.

Documents related to general meetings are found in the table below.

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)

Download our fact sheet: Ascelia Pharma Factsheet Dec 2020